Published Jun 15, 2020
#345 Dexcom CEO Returns
Dexcom CEO Kevin Sayer shares transformative insights on the latest continuous glucose monitoring innovations, revealing their impact on diabetes management and healthcare policy, alongside global expansion efforts, particularly in Europe.

Topics covered
Popular Clips
Questions from this episode
Episode Highlights
Related Episodes


#234 Dexcom CEO Kevin Sayer Returns
Answers 383 questions

#116 Dexcom Update with CEO Kevin Sayer
Answers 383 questions

#694 Dexcom CEO chats from ADA 2022
Answers 383 questions

#498 Dexcom G7 Talk With Dexcom CEO Kevin Sayer
Answers 383 questions

#239 Dexcom Suggestion Box
Answers 383 questions

#158 Dexcom G6 Overview With Dexcom President Kevin Sayer
Answers 383 questions

#954 Dexcom COO Jake Leach: G7, G6, Type 2 and your Questions
Answers 383 questions

#112 Bigfoot Biomedical Returns
Answers 383 questions

#418 Dexcom G7 Update
Answers 383 questions

#334 Dexcom's Tomas Walker is Back
Answers 383 questions

#194 Dexcom Returns
Answers 383 questions

Dexcom CEO talks Servers, Control IQ and more
Answers 383 questions

#184 Jake Leach is Back
Answers 383 questions

#233 A Rose By Any Other Name
Answers 383 questions

#510 Dexcom G7 App Refresh with Dexcom CTO
Answers 383 questions











